COYA — Coya Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1835022 ·
Last close
$4.98
Market Cap
$116.82M
52W High
$7.75
52W Low
$3.71
ADV30
130,386
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 243,745 | — | -7,046,988 | -6,638,260 | 47,308,078 | 43,181,002 | 4,032,067 |
| Mar 2026 | 251,147 | — | -7,640,217 | -7,206,990 | 53,271,099 | 50,724,643 | 4,300,739 |
| Dec 2025 | 3,959,999 | — | -6,030,888 | -5,708,542 | 49,950,245 | 46,822,786 | 6,922,015 |
| Sep 2025 | 3,564,254 | — | -2,432,897 | -2,115,831 | 32,042,878 | 28,129,866 | 4,758,387 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-14,119,556
Investing CF
$-2,049,602
Financing CF
$31,363,177
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.25
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-69,170,267
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-22,518,520
Pretax Income TTM
$-21,123,251
Interest Exp TTM
—
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$8,019,145
EBITDA
$-20,830,436
Free Cash Flow
$-10,944,188
Enterprise Value
$59,564,376
Total Cash
$43,181,000
Total Debt
$0
Shares Out
23,457,849
Trailing EPS
$-1.07
Book Value
$1.84
ROE
-60.5%
ROA
-32.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 7,945,753 | -22,555,225 | -21,226,107 | 49,950,245 | 6,922,015 | 43,028,230 | -10,739,301 |
| Dec 2024 | 3,554,061 | -17,249,711 | -14,880,787 | 44,347,016 | 4,769,921 | 39,577,095 | -10,288,822 |
| Dec 2023 | 6,002,206 | -7,903,349 | -7,987,836 | 41,262,274 | 5,626,665 | 35,635,609 | -11,188,811 |
| Dec 2022 | 0 | -9,811,939 | -12,244,776 | 8,395,566 | 16,789,111 | -8,393,545 | -7,239,354 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.88
Max Pain — expiry 2026-11-20 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $4.98 · call volume: 115 · put volume: 104
Expected Move to 2026-11-20:
±$2.06
(41.37%) —
implied range
$2.92 –
$7.04
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CPIX | CUMBERLAND PHARMACEUTICALS INC | $115.67M | $7.72 | — |
| AARD | Aardvark Therapeutics, Inc. | $115.33M | $5.27 | — |
| QUCY | Quantum Cyber N.V. | $114.33M | $1.36 | — |
| VTVT | vTv Therapeutics Inc. | $120.67M | $30.52 | — |
| INO | INOVIO PHARMACEUTICALS, INC. | $120.98M | $1.17 | — |
News headlines (Yahoo Finance, 1h cache)
Coya Therapeutics Announces Publication of Preclinical Study Demonstrating Combination Immunomodulatory Effects of COYA 303 in a Well-Established Model of Peripheral and CNS Inflammation
2026-09-08 12:00 · Yahoo
Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
2026-06-15 12:00 · Yahoo
Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase
2026-06-08 12:00 · Yahoo
Coya Therapeutics secures FDA fast track status for COYA 302
2026-05-14 11:15 · Yahoo
Coya Therapeutics Announces Enrollment of 100th Participant in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
2026-09-15 12:00 · Yahoo
Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
2026-08-11 12:00 · Yahoo
Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year?
2026-06-30 13:40 · Yahoo
Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting
2026-06-18 12:00 · Yahoo
Hantavirus Outbreak Shows Need for Broad-Spectrum Antiviral Drugs
2026-05-12 12:35 · Yahoo
NanoViricides’ Measles Treatment Granted Orphan Drug Designation by FDA
2026-05-06 12:35 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.